BACKGROUND International benchmarking can help identify trauma system performance issues and determine the extent to which other countries also experience these. When problems are identified, countries can look to high performers for insight into possible responses. The objective of this study was to compare the treatment and outcome of severely injured patients in Germany and Navarra, Spain. ...

INTRODUCTION Traumas represent the cause of 10 % of deaths in the entire world. The successful development of trauma systems, including the use of trauma registries, played a significant part in lowering the mortality and the disabilities due to injuries resulted from trauma. METHOD Review of the literature using computerized database of National Library of Medicine and the International Inst...

Clinical registries have systematically shown that routine clinical practice deals with sicker patients and faces higher morbidity and mortality than the artificial environment of strictly defined randomized-controlled trials might otherwise suggest. The series of Terkelsen et al., in the present issue of the European Heart Journal, focuses on a cohort of 654 patients, representing all patients...

This study aims to estimate the total number of poisoning cases and completeness foodborne disease surveillance in region Tanger-Tétouan-Al Hoceima North West Morocco. retrospective was conducted assess food system over a three-year period from January 1, 2014 December 31, 2016. The data used for this were obtained two sources, including national database Moroccan Poison Control Center (MPCC) p...

OBJECTIVE To evaluate the quality of data on acute myocardial infarction deaths from mortality information systems. METHODS Data on in-hospital acute myocardial infarction mortality collected from database of the Mortality Information System (SIM) and Hospital Information System (SIH), in 2000, were analyzed. Then data collected from medical records from two hospitals affiliated to the Unifie...

Orphan drugs are often approved under exceptional circumstances, requiring submission of additional data on safety and effectiveness through registries. These registries are mainly focused on one drug only and data is frequently incomplete. Some registries also address phenotypic heterogeneity and natural history data and publications on these aspects have contributed to the knowledge and aware...